GSK plc reports

Company location
London
GSK plc has filed 6,801 SEC EDGAR filings since 12 Jan 2001

SEC filing history

Showing 476-500 of 1,000 matching filings.

Per page
25
Current page
20
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
02 Apr 2025
Reporting date
02 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TOTAL VOTING RIGHTS

Filing date
01 Apr 2025
Reporting date
01 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
01 Apr 2025
Reporting date
01 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
31 Mar 2025
Reporting date
31 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A

SCHEDULE 13D/A filing

Filing date
28 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
28 Mar 2025
Reporting date
28 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
28 Mar 2025
Reporting date
28 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
27 Mar 2025
Reporting date
27 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
26 Mar 2025
Reporting date
26 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

GSK UUTI TREATMENT APPROVED BY US FDA

Filing date
25 Mar 2025
Reporting date
25 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
25 Mar 2025
Reporting date
25 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

NOTICE OF AGM

Filing date
24 Mar 2025
Reporting date
24 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

EMA FILING ACCEPTANCE FOR NUCALA COPD

Filing date
24 Mar 2025
Reporting date
24 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
24 Mar 2025
Reporting date
24 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
21 Mar 2025
Reporting date
21 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
21 Mar 2025
Reporting date
21 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
20 Mar 2025
Reporting date
20 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
19 Mar 2025
Reporting date
19 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
CERT File 001-15170

NYSE CERTIFICATION

Filing date
18 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CERT File 001-15170

NYSE CERTIFICATION

Filing date
18 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
18 Mar 2025
Reporting date
18 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
17 Mar 2025
Reporting date
17 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
14 Mar 2025
Reporting date
14 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
14 Mar 2025
Reporting date
14 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12B File 001-15170

8-A12B

Filing date
13 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .